JEFFREY COPELAND: Open Payments
NPI 1811905078 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 8 payments from 5 companies in 2025. Trend: 2023 $315 · 2024 $290 · 2025 $234
Food & beverage: $133Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| Tris Pharma Inc | 3 | $59 |
| Alkermes, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Dyanavel XR, ARISTADA, COBENFY, INGREZZA.
Industry payments across KS — which companies pay providers there.
